Analyst Price Targets — LFVN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 5, 2026 1:47 pm | Brooks O'Neil | Loop Capital Markets | $5.00 | $4.54 | StreetInsider | Lifevantage Corporation (LFVN) PT Lowered to $5 at Lake Street Capital Markets |
| February 5, 2026 1:45 pm | — | Lake Street | $5.00 | $4.60 | TheFly | LifeVantage price target lowered to $5 from $12 at Lake Street |
| November 5, 2025 2:10 pm | Ryan Meyers | Lake Street | $12.00 | $7.03 | TheFly | LifeVantage price target lowered to $12 from $30 at Lake Street |
| January 14, 2025 12:42 pm | Alex Fuhrman | Craig-Hallum | $35.00 | $16.45 | TheFly | LifeVantage initiated with a Buy at Craig-Hallum |
| January 10, 2025 1:44 pm | Brooks O'Neil | Lake Street | $30.00 | $22.52 | TheFly | LifeVantage price target raised to $30 from $26 at Lake Street |
| December 19, 2024 1:17 pm | Brooks O'Neil | Lake Street | $26.00 | $14.60 | TheFly | LifeVantage initiated with a Buy at Lake Street |
Latest News for LFVN
SALT LAKE CITY, April 16, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the appointment of Terrence Moorehead as the Company's new President and Chief Executive Officer and as a member of the Board of Directors (the “Board”),…
Lifevantage Corporation (NASDAQ: LFVN - Get Free Report)'s share price crossed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $6.22 and traded as low as $4.08. Lifevantage shares last traded at $4.35, with a volume of 137,581 shares. Analysts Set New Price Targets A number of
SALT LAKE CITY, April 09, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer, Kristen Cunningham, Chief Sales Officer, and Lisa Barnes, Vice President Research & Development and Regulatory, will participate in the…
SALT LAKE CITY, April 02, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, announced today it will be expanding its products and business opportunity in Portugal, welcoming a new wave of purpose-driven entrepreneurs and wellness seekers to its growing international community. This…
SALT LAKE CITY, March 16, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the Sidoti Small Cap Conference, to be held March 18-19, 2026. Mr. Fife and…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for LFVN.
U.S. House Trading
No House trades found for LFVN.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.